Royal Bank of Canada
TRPX

Royal Bank of Canada’s Therapix Biosciences Ltd. TRPX Stock Holding History

Royal Bank of Canada’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$6K – 7115
2017
Q3 		$6K Hold
1,000
– – ﹤0.01% 6408
2017
Q2 		$7K Hold
1,000
– – ﹤0.01% 5951
2017
Q1 		$8K Buy
+1,000
New +$8.79K ﹤0.01% 6082

Other funds holding TRPX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Royal Bank of Canada's TRPX Position: Q4 2017 in Review

Royal Bank of Canada sold out of Therapix Biosciences Ltd. (TRPX) in Q4 2017, closing a stake of 1,000 shares — an estimated $6K sold.

Royal Bank of Canada first reported a position in TRPX in Q1 2017 and held it in 3 quarters. The position peaked at $8K in Q1 2017. 5 funds tracked by Wall St. Rank hold TRPX as of Q4 2017.

  • Royal Bank of Canada reported no remaining Therapix Biosciences Ltd. position as of Q4 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 1,000 Therapix Biosciences Ltd. shares in Q4 2017, an estimated $6K.
  • Royal Bank of Canada first reported a position in Therapix Biosciences Ltd. in Q1 2017 and held it in 3 quarters.
  • Royal Bank of Canada's Therapix Biosciences Ltd. position peaked at $8K in Q1 2017.
  • 5 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.